Additionally, we performed modification omics on CRC cell lines to screen for sialic acid–modified substrates and identified galectin-3 binding protein (also known as Mac-2 BP, 90K, or LGALS3BP) as a novel sialylation target. Here, LGALS3BP is linked to colorectal carcinoma.